Zovirax Double Strength 400mg/5ml oral suspension

Ország: Egyesült Királyság

Nyelv: angol

Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktív összetevők:

Aciclovir

Beszerezhető a:

GlaxoSmithKline UK Ltd

ATC-kód:

J05AB01

INN (nemzetközi neve):

Aciclovir

Adagolás:

80mg/1ml

Gyógyszerészeti forma:

Oral suspension

Az alkalmazás módja:

Oral

Osztály:

No Controlled Drug Status

Recept típusa:

Valid as a prescribable product

Termék összefoglaló:

BNF: 05030201; GTIN: 5000123110834

Betegtájékoztató

PACKAGE LEAFLET: INFORMATION FOR THE USER
ZOVIRAX® DOUBLE STRENGTH SUSPENSION
ACICLOVIR
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
•
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1
What Zovirax is and what it is used for
2
What you need to know before you take Zovirax
3
How to take Zovirax
4
Possible side effects
5
How to store Zovirax
6
Contents of the pack and other information
1 WHAT ZOVIRAX IS AND WHAT IT IS USED FOR
Zovirax Double Strength Suspension (called ‘Zovirax’ in this
leaflet) contains a medicine called
aciclovir. This belongs to a group of medicines called antivirals. It
works by killing or stopping the
growth of viruses.
Zovirax can be used to:
•
treat chickenpox and shingles
•
treat cold sores, genital herpes and other herpes simplex infections
•
stop these problems returning after you have had them
•
stop these problems in people whose immune systems work less well,
which means their bodies
are less able to fight infections
2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZOVIRAX
DO NOT USE ZOVIRAX IF:
•
you are allergic to aciclovir or valaciclovir or any of the other
ingredients of this medicine (listed in
Section 6).
Do not take Zovirax if the above applies to you. If you are not sure,
talk to your doctor or pharmacist
before taking Zovirax.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Zovirax if:
•
you have kidney problems
•
you are over 65 years of age.
If you are not sure if the above apply to you, talk to your doctor or
pharmacist before taking Zovirax.
It is important that you drink

Termékjellemzők

OBJECT 1
ZOVIRAX DOUBLE-STRENGTH SUSPENSION
Summary of Product Characteristics Updated 10-Mar-2017 |
GlaxoSmithKline UK
1. Name of the medicinal product
Zovirax
®
Double Strength Suspension
2. Qualitative and quantitative composition
Aciclovir BP 400mg/5ml
Excipients with known effect:
Methyl parahydroxybenzoate
Propyl parahydroxybenzoate
Sorbitol Solution, 70%, non-crystallising
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Suspension
4. Clinical particulars
4.1 Therapeutic indications
Zovirax Double Strength Suspension is indicated for the treatment of
herpes simplex virus infections of
the skin and mucous membranes including initial and recurrent genital
herpes (excluding neonatal HSV
and severe HSV infections in immunocompromised children).
Zovirax Double Strength Suspension is indicated for the suppression
(prevention of recurrences) of
recurrent herpes simplex infections in immunocompetent patients.
Zovirax Double Strength Suspension is indicated for the prophylaxis of
herpes simplex infections in
immunocompromised patients.
Zovirax Double Strength Suspension is indicated for the treatment of
varicella (chickenpox) and herpes
zoster (shingles) infections.
4.2 Posology and method of administration
Route of Administration: Oral
_Dosage in Adults_
_Treatment of herpes simplex infections:_ 200mg Zovirax should be
taken five times daily at approximately
four hourly intervals omitting the night time dose. Treatment should
continue for 5 days, but in severe
initial infections this may have to be extended.
In severely immunocompromised patients (eg after marrow transplant) or
in patients with impaired
absorption from the gut the dose can be doubled to 400mg Zovirax or
alternatively intravenous dosing
could be considered.
Dosing should begin as early as possible after the start of an
infection; for recurrent episodes this should
preferably be during the prodromal period or when lesions first
appear.
_Suppression of herpes simplex infections in immunocompetent
patients:_
200mg Zovirax shou